0
0
Melbourne, May 2 – In a discovery that could reshape the fight against antibiotic-resistant infections, Australian researchers have uncovered a previously overlooked virus hidden within pneumonia-causing bacteria. The study, published in Science Advances, reveals that telomere phages-once dismissed as scientific oddities-are both widespread and potentially powerful allies in the battle against superbugs.
Telomere phages are a type of bacteriophage, viruses that infect bacteria. While their unique DNA replication had been studied, their broader impact on bacterial biology remained unknown. Now, a research team led by Monash University’s Biomedicine Discovery Institute has found these phages embedded within Klebsiella, a genus of bacteria responsible for pneumonia and other serious, drug-resistant infections.
“For more than 20 years of intensive bacterial genomics, telomere phages had remained hidden in plain sight. We have missed an entire aspect of biology,” said Professor Trevor Lithgow, head of the lab that made the discovery.
How Telomere Phages Tip the Balance
The breakthrough came as scientists sequenced a clinical strain of Klebsiella and identified a fourth telomere phage. Further analysis revealed that these phages are present in thousands of Klebsiella lineages, including both clinical and environmental strains.
Crucially, bacteria carrying telomere phages produce toxins called “telocins.” These telocins enable the host bacteria to kill off neighboring rivals-including drug-resistant strains-giving “good” bacteria an edge over their more dangerous, antibiotic-resistant cousins.
“This opens up a new bacterial management strategy,” explained Professor Lithgow. “The phage-carrying bacteria essentially act as enforcers, eliminating drug-resistant threats nearby”.
Dr. Sally Byers, a researcher in the Lithgow Lab, added, “We now want to understand how the host secretes the toxin and how the toxin infiltrates neighboring bacteria”.
Implications for the Fight Against Superbugs
The findings suggest that harnessing telomere phages and their toxins could one day provide a natural, targeted alternative to antibiotics-potentially slowing the rise of deadly superbugs that threaten global health. The team also believes similar phages may exist in other bacterial species, broadening the scope for future antimicrobial strategies.
Klebsiella, particularly K. pneumoniae, is a major cause of hospital-acquired infections and is increasingly resistant to conventional antibiotics7. The discovery that “good” bacteria can be equipped by hidden viruses to fight off “bad” bacteria marks a promising advance in the ongoing battle against antimicrobial resistance.
Disclaimer: This article is based on findings published in peer-reviewed scientific journals and statements from researchers. The potential for telomere phages or their toxins to be used in clinical treatments remains under investigation and is not yet approved for medical use. Readers should consult healthcare professionals for medical advice and rely on established antibiotics and infection control practices until further research is validated.
Citations:
